Tracking Karyotype Changes in Treatment-Induced Drug-Resistant Evolution.

Area of Science:

• Genomics
• Cancer Biology
• Evolutionary Biology

Background:

• Karyotype characterization is crucial for understanding cancer's macroevolution and gene organization.
• Rapid drug resistance in cancer highlights the need for advanced cytogenomic monitoring tools.

Purpose of the Study:

• To outline protocols for monitoring the karyotype landscape during treatment-induced rapid drug resistance in cancer.
• To advance the concept and platforms for cancer cytogenetics and cytogenomics.

Main Methods:

• Utilizing combinational analyses of phenotype and karyotype.
• Employing longitudinal analysis to study the entire evolutionary process.
• Comparing whole landscape dynamics using various numerical chromosome abnormality (NCCA) types, including genome chaos, across different genomic scales.

Main Results:

• The study provides a framework for analyzing karyotype dynamics in response to cancer treatment.
• The proposed protocols enable detailed monitoring of treatment-induced drug resistance.
• Integration of diverse analytical perspectives enhances the understanding of cancer evolution.

Conclusions:

• The developed protocol offers a promising approach for studying various evolutionary aspects of cancers.
• This methodology significantly enhances the power of karyotype analysis in cancer research.
• It provides a robust platform for investigating cancer cytogenomics and evolutionary trajectories.